USD 0.03
(-10.45%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -59.07 Thousand CAD | -91.28% |
2023 | -30.88 Thousand CAD | -349.4% |
2022 | -6872.00 CAD | -321.6% |
2021 | -1630.00 CAD | 50.29% |
2020 | -3279.00 CAD | 49.86% |
2019 | -6540.00 CAD | -44.15% |
2018 | -4537.00 CAD | 0.0% |
2017 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | -14.59 Thousand CAD | 3.41% |
2024 FY | -59.07 Thousand CAD | -91.28% |
2024 Q4 | -14.82 Thousand CAD | -1.55% |
2024 Q1 | -14.53 Thousand CAD | -1.25% |
2024 Q2 | -15.11 Thousand CAD | -3.97% |
2023 Q3 | -10.42 Thousand CAD | -209.65% |
2023 Q4 | -14.35 Thousand CAD | -37.71% |
2023 FY | -30.88 Thousand CAD | -349.4% |
2023 Q1 | -2732.00 CAD | -1125.11% |
2023 Q2 | -3367.00 CAD | -23.24% |
2022 Q2 | -3524.00 CAD | -287.68% |
2022 Q1 | -909.00 CAD | -128.97% |
2022 FY | -6872.00 CAD | -321.6% |
2022 Q4 | -223.00 CAD | 89.94% |
2022 Q3 | -2216.00 CAD | 37.12% |
2021 Q3 | -269.50 CAD | -22816.5% |
2021 Q2 | -1.18 CAD | -396.2% |
2021 FY | -1630.00 CAD | 50.29% |
2021 Q1 | -0.24 CAD | 99.56% |
2021 Q4 | -397.00 CAD | -47.31% |
2020 FY | -3279.00 CAD | 49.86% |
2020 Q4 | -54.44 CAD | -477.94% |
2020 Q3 | -9.42 CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | -100.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 FY | -6540.00 CAD | -44.15% |
2019 Q3 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | -200.00 CAD | 0.0% |
2018 Q3 | 13.48 CAD | 106.74% |
2018 Q4 | 166.56 CAD | 1135.63% |
2018 FY | -4537.00 CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 69.392% |
Arrayit Corporation | 2.57 Million USD | 102.294% |
Atlantic International Corp. | -154.23 Thousand USD | 61.699% |
Biocept, Inc. | -2.58 Million USD | 97.712% |
Bioqual, Inc. | 7.42 Million USD | 100.795% |
CardioGenics Holdings Inc | - USD | Infinity% |
DermTech, Inc. | 276 Thousand USD | 121.403% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.001% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 103.293% |
iMD Companies, Inc. | -23.63 Thousand USD | -149.918% |
IDenta Corp. | 662.97 Thousand USD | 108.91% |
Interpace Biosciences, Inc. | 23.04 Million USD | 100.256% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | 176.153% |
InVitro International | 635.98 Thousand USD | 109.288% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | 100.9% |
Many Bright Ideas Technologies Inc. | - USD | Infinity% |
Medical Imaging Corp. | 1.09 Million USD | 105.406% |
NovelStem International Corp. | 12 Thousand USD | 592.275% |
Optigenex Inc. | -102.96 Thousand USD | 42.629% |
PharmChem, Inc. | 3.9 Million USD | 101.513% |
Proteome Sciences plc | 2.09 Million USD | 102.818% |
Response Genetics, Inc | 3.94 Million USD | 101.499% |
Rennova Health, Inc. | 6.26 Million USD | 100.942% |
RushNet, Inc. | 1.1 Million USD | 105.348% |
ScreenPro Security Inc. | 856.57 Thousand USD | 106.896% |
Stella Diagnostics Inc. | - USD | Infinity% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 85.369% |
Todos Medical Ltd. | 4.31 Million USD | 101.371% |